ATAI Life Sciences
ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders.
They are committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space.
By pooling expertise, best practices, and resources across ATAI’s entire portfolio, they mitigate risk and responsibly accelerate the development of impactful and evidence-based treatments.
INDUSTRY
BIOTECHNOLOGY
OUR ROLE
INVESTOR
SINCE
2019
BASED IN
BERLIN, GERMANY